Stanley Laman Group, Ltd. Illumina, Inc. Transaction History

Stanley Laman Group, Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$361.28 - $504.76 $5.44 Million - $7.6 Million	-15,059 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$292.7 - $370.96 $399,535 - $506,360	1,365 Added 9.97%	15,059 $5.57 Million
Q3 2020 Oct 20, 2020	BUY	$268.51 - $400.74 $363,831 - $543,002	1,355 Added 10.98%	13,694 $4.23 Million
Q2 2020 Jul 20, 2020	SELL	$256.46 - $373.01 $226,967 - $330,113	-885 Reduced 6.69%	12,339 $4.57 Million
Q1 2020 May 12, 2020	BUY	$209.2 - $335.53 $2.77 Million - $4.44 Million	13,224 New	13,224 $3.61 Million
Q4 2019 Feb 04, 2020	SELL	$288.29 - $335.49 $244,469 - $284,495	-848 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$266.84 - $378.23 $2,134 - $3,025	-8 Reduced 0.93%	848 $258,000
Q2 2019 Aug 01, 2019	BUY	$300.59 - $368.15 $257,305 - $315,136	856 New	856 $315,000

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stanley Laman Group, Ltd. with notifications on news.